Reduced bone mineral density in Japanese premenopausal women with systemic lupus erythematosus treated with glucocorticoids

Modern Rheumatology

Volumn 12, Issue 4, 2002, Pages 323-328

  Banno, Shogo ^a   Matsumoto, Yoshifuji ^a   Naniwa, Taio ^a   Hayami, Yoshihito ^a   Sugiura, Yoshiki ^a   Yoshinouchi, Takeo ^a   Ueda, Ryuzo ^a  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

Bone metabolic marker; Bone specific alkaline phosphatase (BAP); Glucocorticoid induced osteoporosis; Systemic lupus erythematosus (SLE); Type I collagen cross linked N telopeptides (NTx)

Indexed keywords

ALKALINE PHOSPHATASE; BIOLOGICAL MARKER; COLECALCIFEROL; COLLAGEN TYPE 1; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; PEPTIDE DERIVATIVE; PREDNISOLONE;

ADULT; ARTICLE; BONE MINERAL; CAUCASIAN; CONTROLLED STUDY; CORRELATION ANALYSIS; DOSE RESPONSE; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HUMAN; INCIDENCE; JAPAN; LOGISTIC REGRESSION ANALYSIS; LUMBAR VERTEBRA; MAJOR CLINICAL STUDY; OSSIFICATION; OSTEOLYSIS; OSTEOPENIA; OSTEOPOROSIS; PREDICTION; PREMENOPAUSE; PRIORITY JOURNAL; RACE DIFFERENCE; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0037005277     PISSN: 14397595     EISSN: None     Source Type: Journal    
DOI: 10.1007/s101650200057     Document Type: Article

References (21)

1. Zonana-Nacach A, Barr SG, Magder LS, Petri M. Damage in systemic lupus erythematosus and its association with corticosteroids. Arthritis Rheum 2000;43:1801-8.
2. Eastell R, Reid DM, Compston J, Cooper C, Fogelman I, Francis RM, et al. A UK consensus group on management of glucocorticoid-induced osteoporosis: an update. J Intern Med 1998;244:271-92.
3. Hayashi Y, Kushida K, Kitazawa A, Tanizawa T, Hotokebuchi T, Hagino H, et al. Measurement of vertebral body dimensions of the thoracic and lumbar spines of 242 healthy women. J Bone Miner Metab 1998;16:27-33.
4. Hanson DA, Weis MA, Bollen A-M, Maslan SL, Singer FR, Eyre DR. A specific immunoassay for monitoring human bone resorption: quantitation of type I collagen cross-linked N-telopeptides in urine. J Bone Miner Res 1992;7:1251-8.
5. Gomez B, Ardakani S, Ju J, Jenkins D, Cerelli MJ, Daniloff GY, et al. Monoclonal antibody assay for measuring bone-specific alkaline phosphatase activity in serum. Clin Chem 1995;41:1560-6.
6. Formiga F, Moga I, Nolla JM, Pac M, Mitjavila F, Roig-Escofet D. Loss of bone mineral density in premenopausal women with systemic lupus erythematosus. Ann Rheum Dis 1995;54:274-6.
7. Dhillon VB, Davies MC, Hall ML, Round JM, Ell PJ, Jacobs HS, et al. Assessment of the effect of oral corticosteroids on bone mineral density in systemic lupus erythematosus: a preliminary study with dual energy x ray absorptiometry. Ann Rheum Dis 1990;49:624-6.
8. Kalla AA, Fataar AB, Jessop SJ, Bewerunge L. Loss of trabecular bone mineral density in systemic lupus erythematosus. Arthritis Rheum 1993;36:1726-34.
9. Gilboe I-M, Kvien TK, Haugeberg G, Husby G. Bone mineral density in systemic lupus erythematosus: comparison with rheumatoid arthritis and healthy controls. Ann Rheum Dis 2000;59:110-15.
10. Pons F, Peris P, Guanabens N, Font J, Huguet M, Espinosa G, et al. The effect of systemic lupus erythematosus and long-term steroid therapy on bone mass in pre-menopausal women. Br J Rheumatol 1995;34:742-6.
11. Kipen Y, Buchbinder R, Forbes A, Strauss B, Geoffrey L, Morand E. Prevalence of reduced bone mineral density in systemic lupus erythematosus and the role of steroids. J Rheumatol 1997;24:1922-9.
12. Sinigaglia L, Varenna M, Binelli L, Zucchi F, Ghiringhelli D, Gallazzi M, et al. Determinants of bone mass in systemic lupus erythematosus: a cross sectional study on premenopausal women. J Rheumatol 1999;26:1280-4.
13. Li EK, Tam LS, Young RP, Ko GTC, Li M, Lau EMC. Loss of bone mineral density in Chinese pre-menopausal women with systemic lupus erythematosus treated with corticosteroids. Br J Rheumatol 1998;37:405-10.
14. Sugimoto T, Tsutumi M, Fuji Y, Kawatsu M, Kegishi H, Lee MC, et al. Comparison of bone mineral content among Japanese, Koreans, and Taiwanese assessed by dual-photon absorptiometry. J Bone Miner Res 1992;7:153-9
15. Ferrari S, Rizzoli R, Bonjour JP. Genetic aspects of osteoporosis. Curr Opin Rheumatol 1999;11:294-300.
16. Lakshminarayanan S, Walsh S, Mohanraj M, Rothefield N. Factors associated with low bone mineral density in female patients with systemic lupus erythematosus. J Rheumatol 2001;28:102-8.
17. Kyd PA, Vooght KD, Kerkhoff F, Thomas E, Fairney A. Clinical usefulness of biochemical resorption markers in osteoporosis. Ann Clin Biochem 1999;36:483-91.
18. Masatomi C, Imai K, Wang DH, Ikeda S, Taketa K, Takata K, et al. Urinary excretion of type I collagen cross-linked N-telopeptides, bone mass and related lifestyle in middle-aged women. Acta Med Okayama 1999;53:133-40.
19. Schneider DL, Barrett-Connor EL. Urinary N-telopeptide levels discriminate normal, osteopenic, and osteoporotic bone mineral density. Arch Intern Med 1997;157:1241-5.
20. Kipen Y, Briganti E, Strauss B, Will R, Littlejohn G, Morand E. Three-year followup of bone mineral density change in premenopausal women with systemic lupus erythematosus. J Rheumatol 1999;26:310-7.
21. Eriksen EF, Brixen K, Chares P. New markers of bone metabolism: clinical use in metabolic bone disease [review]. Eur J Endocrinol 1995;132:244-60.